|1.||Sairam, M Ram: 6 articles (02/2014 - 04/2006)|
|2.||Ghinea, Nicolae: 5 articles (01/2015 - 10/2010)|
|3.||Latronico, Ana Claudia: 5 articles (01/2013 - 06/2005)|
|4.||Sairam, M R: 5 articles (06/2012 - 11/2000)|
|5.||Smits, Guillaume: 5 articles (12/2004 - 08/2003)|
|6.||Vassart, Gilbert: 5 articles (12/2004 - 08/2003)|
|7.||Costagliola, Sabine: 5 articles (12/2004 - 08/2003)|
|8.||Mahale, Smita D: 4 articles (04/2015 - 02/2009)|
|9.||Pichon, Christophe: 4 articles (01/2015 - 10/2010)|
|10.||Sun, Hong: 4 articles (09/2013 - 07/2008)|
10/01/2015 - "Follicle-Stimulating Hormone Receptor as a Target in the Redirected T-cell Therapy for Cancer."
02/02/2015 - "PET of follicle-stimulating hormone receptor: broad applicability to cancer imaging."
01/01/2015 - "Follicle-stimulating hormone receptor (FSHR) is expressed on the endothelial surface of blood vessels associated with solid tumor periphery, where angiogenesis is known to occur. "
01/01/2015 - "It is indeed paradoxical that scientists searched for mutations in FSH receptor (FSHR) expressed on granulosa cells, whereas more than 90% of cancers arise in ovary surface epithelium (OSE). "
08/01/2014 - "Follicle-stimulating hormone receptor (FSHR) is overexpressed in primary and metastatic tumor. "
|2.||Body Weight (Weight, Body)
09/10/2013 - "In vivo studies showed that FSH81-NP-PTXs possessed higher antitumor efficacy against FSH receptor-expressing tumors without any clinical signs of adverse side effects or body weight loss due to modification with FSH β 81-95 peptide. "
04/01/2002 - "Daily administration of 6 microg DHT kg(-1) body weight to gilts from day 13 of the oestrous cycle to the following oestrus (Expt 3) did not affect the relative amounts of androgen receptor mRNA, but increased (P < 0.05) the amounts of FSH receptor mRNA in preovulatory follicles as determined by RT-PCR. "
02/01/2009 - "All four fasted groups were fasted for 2 days and then ad libitum and the ducks were treated with leptin at doses of 0 (control and FC), 50 (F+L), 250 (F+M) and 1000 (F+H) microg/kg body weight/day on day 3-5. Results showed that a moderate dose of leptin (250 microg/kg body weight/day) injected during the re-feeding period: (i) promoted the recovery of the regressed ovary as evidenced by an increase in ovary weight and recovery of yellow hierarchical follicles; (ii) elevated the plasma 17beta-estradiol (E(2)) level; (iii) increased the mRNA levels of ovary follicle-stimulating hormone receptor (FSHR), luteinizing hormone receptor (LHR) and estrogen receptor-beta (ER-beta). "
|3.||Hypogonadism (Hypergonadotropic Hypogonadism)
04/21/2006 - "Neither FSHbeta nor FSH receptor (FSHR) null mice have bone loss despite severe hypogonadism. "
02/01/2003 - "Inactivating mutations of the FSH receptor (FSHR) are a rare cause of hypergonadotrophic hypogonadism in women. "
02/01/2003 - "A novel loss of function mutation in exon 10 of the FSH receptor gene causing hypergonadotrophic hypogonadism: clinical and molecular characteristics."
10/01/2000 - "Inactivating mutations of FSH receptor are involved in some cases of hypergonadotropic hypogonadism with a more severe impairment of fertility in female patients. "
02/01/2002 - "Inactivating mutations in the gene for the FSH receptor are involved in some female patients of hypergonadotropic hypogonadism with infertility. "
11/01/2013 - "The FSH receptor (FSHR), which was previously believed to be expressed primarily in the ovary and testis, was recently found to be expressed in the tumor blood vessels of many solid tumor types, including prostate adenocarcinoma, urothelial carcinoma, and renal cell carcinoma. "
02/01/2003 - "The number of mice with ovarian pathology, reminiscent of the serous ovarian adenocarcinomas found in humans, was significantly greater in the FSHbetaKO mice, indicating that the presence of an intact FSH receptor on ovarian cells of FSHbetaKO females may allow constitutive basal stimulation of the ovary, which is absent in mice lacking FSH receptors."
|5.||Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
11/01/2014 - "The aim of this study was to explore the association between follicle stimulating hormone receptor (FSHR) Thr307Ala and Asn680Ser polymorphisms and susceptibility to polycystic ovary syndrome (PCOS). "
12/01/2006 - "This study was designed to assess the relationship between mutations in the FSH receptor (FSHr) gene and polycystic ovary syndrome (PCOS) in Italian women. "
03/01/2015 - "To investigate the association between two polymorphisms of follicle stimulating hormone receptor (FSHR) gene and polycystic ovary syndrome (PCOS) susceptibility. "
03/01/2015 - "Association between two polymorphisms of follicle stimulating hormone receptor gene and susceptibility to polycystic ovary syndrome: a meta-analysis."
11/01/2014 - "Two follicle-stimulating hormone receptor polymorphisms and polycystic ovary syndrome risk: a meta-analysis."
|1.||FSH Receptors (FSH Receptor)
|2.||Follicle Stimulating Hormone (Follitropin)
|4.||Chorionic Gonadotropin (Human Chorionic Gonadotropin)
|5.||LH Receptors (LH Receptor)
|6.||Luteinizing Hormone (Lutropin)
|7.||Messenger RNA (mRNA)
|10.||Stem Cell Factor
|1.||Heterologous Transplantation (Xenotransplantation)
|4.||Drug Therapy (Chemotherapy)